Waystar (WAY) Stock May Be 46% Undervalued Despite Raised Guidance

Waystar Holding Corp.

Waystar Holding Corp.

WAY

0.00

Waystar Holding stock has declined 31.2% over the past year, yet the current checks send a mixed message on value as a Discounted Cash Flow (DCF) intrinsic value estimate points to upside while traditional market multiples lean the other way.

  • The share price is down 31.2% over the last 12 months. This puts renewed attention on whether recent weakness has already priced in investor concerns.
  • Growing adoption of Waystar Holding's healthcare payment software and recognition for its connected revenue cycle platform can support higher cash flow expectations. At the same time, any shift in sentiment around execution or competitive intensity may weigh on how much investors are willing to pay for that growth.
  • The stock screens as undervalued on a Discounted Cash Flow (DCF) view, with the intrinsic value estimate sitting 46.1% above the current price. However, the broader checks and market multiples point to a mixed picture rather than a clear bargain, with the company passing 4 of 6 valuation tests on value score 4.

The issue now is whether Waystar Holding's recent share price decline and the split between intrinsic value and market multiples leave enough margin of safety for investors.

Is Waystar Holding Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model estimates what Waystar Holding might be worth based on the cash it is expected to generate for shareholders. For Waystar Holding, the model starts with latest twelve month free cash flow of about $296.8 million and then assumes that cash generation continues to grow rather than shrink over the coming years.

On these cash flow projections, the DCF points to an estimated intrinsic value of about $45.53 per share, which is 46.1% above the current market price. Because Waystar recently raised its 2026 revenue and adjusted EBITDA guidance, the stronger operating outlook helps explain why the DCF result is well above where the stock trades today.

On cash flow grounds the stock currently screens as undervalued compared with the DCF estimate of intrinsic value.

Our Discounted Cash Flow (DCF) analysis suggests Waystar Holding is undervalued by 46.1%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.

WAY Discounted Cash Flow as at Jul 2026
WAY Discounted Cash Flow as at Jul 2026

Does Waystar Holding Look Pricey on Earnings?

P/E is a useful lens for Waystar Holding because it ties the share price directly to the earnings that the business is currently generating. On this measure, Waystar trades at about 37.3x earnings, which is above the Healthcare Services industry average of roughly 26.8x but below a peer group average near 47.8x. That places the stock between the broader sector and closer high growth peers.

The tailored fair P/E ratio for Waystar Holding sits at around 30.3x, which is below the current 37.3x level. This indicates that investors are already paying a premium to what this framework suggests would be reasonable given the company’s profile. The gap is not extreme, yet it leaves less room for error if expectations around execution or competition change.

On a P/E basis, Waystar Holding currently appears overvalued relative to the earnings multiple that the modelled fundamentals would support.

NasdaqGS:WAY P/E Ratio as at Jul 2026
NasdaqGS:WAY P/E Ratio as at Jul 2026

The Waystar Holding Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Waystar Holding pick up where this valuation puzzle leaves off and spell out the specific paths that could make the stock worth materially more or less than today’s price. Each narrative links its numbers to a clear view of how Waystar Holding's growth, margins and risks might develop, which gives you something concrete to revisit as new information is released.

One of the top community narratives on Waystar Holding: 44% undervalued

"Waystar’s position in the payment flow, processing over 7b transactions annually and touching about 60% of the U.S. patient population, creates a reinforcing data and network effect that can help sustain high client retention, support recurring revenue and stabilize earnings…"

Do you think there's more to the story for Waystar Holding? Head over to our Community to see what others are saying!

The Bottom Line

Waystar Holding sits in a genuine valuation tug of war. The Discounted Cash Flow (DCF) view points to meaningful upside based on expected cash generation, while the P/E and other market multiples lean toward the stock being overvalued. That split reflects a clash between what the cash flow profile could support and what current sentiment and peer comparisons are willing to pay. The key issue from here is whether Waystar Holding can deliver on the cash flow and profitability path implied in the intrinsic value estimate, without a shift in competitive or execution risk turning that apparent discount into a value trap.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.